CompletedNot Applicable

Improve Screening Criteria for Retinopathy of Prematurity in Two French Center

France886 participantsStarted 2022-03-21

Plain-language summary

The aim of the study is to assess whether a delay of the first examination can be safely considered in French population. Secondary objectives are to describe retinopathy of prematurity (ROP) in a population of premature from two French tertiary NICU and to identify co-morbidities associated with the development of severe ROP.

Who can participate

Age range0 Years – 31 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Infant with gestational age \< 31 weeks and/or birth weight \< 1250 g * With at least one retinal examination * holders of the parental rights informed and not objecting to the study Exclusion Criteria: * infants died before 28 days PNA * infants with hydrocephaly. * infants with significant congenital malformations or genetic abnormalities.

What they're measuring

Number of infants with type 1 or 2 ROP found at routine screening.

Timeframe: Day 0

Trial details

NCT IDNCT05152862

SponsorCentre Hospitalier Sud Francilien

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-06-16

View on ClinicalTrials.gov More Retinopathy of Prematurity trials